Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors
Abstract Artificial bone graft substitutes, such as Calcibon, are becoming increasingly interesting as they do not cause donor site morbidity which is an advantage compared to autologous bone grafts. The aim of this study was to evaluate the efficacy and potential complications associated with the u...
Guardado en:
Autores principales: | Joerg Friesenbichler, Werner Maurer-Ertl, Marko Bergovec, Lukas A. Holzer, Kathrin Ogris, Lukas Leitner, Andreas Leithner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dced57d5ce424c1daf88dda5487ac74d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cat at home? Cat scratch disease with atypical presentations and aggressive radiological findings mimicking sarcoma, a potential diagnostic pitfall
por: Florian Amerstorfer, et al.
Publicado: (2021) -
Use of Liquid Nitrogen as A local Adjuvant to Decrease Recurrence after Extended Curettage, and Reconstruction by Autogenous Bone Graft for Treatment of Aneurysmal bone Cyst: Our Updated Experience
por: Mohamed Abdel Rahman Mostafa, et al.
Publicado: (2021) -
Short-stem total hip arthroplasty is not associated with an earlier return to work compared to a straight-stem design
por: Georg Hauer, et al.
Publicado: (2021) -
Toxoplasma gondii infection in patients with malignant and benign bone tumours
por: M. Hajizadeh, et al.
Publicado: (2019) -
Benign orbital tumors with bone destruction in children.
por: Jianhua Yan, et al.
Publicado: (2012)